Leef Brands (LEEEF) Capital Expenditures (2025 - 2026)

Leef Brands (LEEEF) reported Capital Expenditures of $494839.0 for Q1 2026, up 205.31% on a YoY basis from $162075.0 in Q1 2025, and up 205.31% sequentially from $162075.0 in Q1 2025.

Leef Brands (LEEEF) Capital Expenditures (2025 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 2 years of Capital Expenditures data on file, last reported at $494839.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn 494,839.00

Historic Data

Download Data
DateValue
Mar 31, 2026 494,839.00
Mar 31, 2026 494,839.00
Mar 31, 2025 162,075.00
Mar 31, 2025 162,075.00